Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91126278 | 9112627 | 8 | F | 20160919 | 20130211 | 20160928 | EXP | US-ROCHE-775066 | ROCHE | , TOTH C, DANIEL E, GRUNWALD J, MAGUIRE M, YING G, HUANG J, MARTIN D, JAFFE G. MACULAR MORPHOLOGY AND VISUAL ACUITY IN THE SECOND YEAR OF THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS. OPHTHALMOLOGY 2016;123 (4):865-875. | 0.00 | Y | 0.00000 | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91126278 | 9112627 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Other | 1.25 MG IN 0.05 ML OF SOLUTION | U | 125085 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 91126278 | 9112627 | 1 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 91126278 | 9112627 | DE |
| 91126278 | 9112627 | OT |
| 91126278 | 9112627 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 91126278 | 9112627 | Angiopathy | |
| 91126278 | 9112627 | Arterial thrombosis | |
| 91126278 | 9112627 | Benign neoplasm | |
| 91126278 | 9112627 | Cardiac disorder | |
| 91126278 | 9112627 | Cerebrovascular accident | |
| 91126278 | 9112627 | Death | |
| 91126278 | 9112627 | Endophthalmitis | |
| 91126278 | 9112627 | Gastrointestinal disorder | |
| 91126278 | 9112627 | Haemorrhage | |
| 91126278 | 9112627 | Hernia | |
| 91126278 | 9112627 | Hypertension | |
| 91126278 | 9112627 | Infection | |
| 91126278 | 9112627 | Myocardial infarction | |
| 91126278 | 9112627 | Nausea | |
| 91126278 | 9112627 | Neoplasm malignant | |
| 91126278 | 9112627 | Nervous system disorder | |
| 91126278 | 9112627 | Pneumonia | |
| 91126278 | 9112627 | Pseudoendophthalmitis | |
| 91126278 | 9112627 | Suspected transmission of an infectious agent via product | |
| 91126278 | 9112627 | Urinary tract infection | |
| 91126278 | 9112627 | Venous thrombosis | |
| 91126278 | 9112627 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |